A UCLA-led research team has discovered a molecular switch that determines whether tiny blood vessels in premature infants' ...
The fourth launch of Nuri and the enactment of the AI Basic Act have been selected as *this year’s top 10 science and technology news*. The Korean Federation of Science and Technology Societies (KOFST ...
Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could ...
Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...
Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...
As the immune system weakens with age, scientists have found a way to restore some of its lost strength. By delivering mRNA ...
A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...
The era of CureVac as an independent, publicly traded company has drawn to a close. BioNTech SE has successfully completed ...
As the immune system weakens with age, researchers have found a way to temporarily boost its function by reprogramming liver cells to support T-cell development.
BioNTech SE has successfully concluded its takeover bid for CureVac N.V., marking a significant consolidation within the mRNA ...
A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...
Moderna will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental ...